Appointment booking for Dr. Asha Muthalaly, MD is currently not available.Dr. Asha Muthalaly, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Asha Muthalaly, MD (she/her) is a Rheumatologist in Joliet, IL with over 16 years of experience. What is your opinion of Dr. Asha Muthalaly, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 16 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Asha Muthalaly, MD has received over $9,373 which includes payments from the following companies:
$1,347.27 from Pfizer Inc.
$1,239.72 from Amgen Inc.
$1,075.95 from AbbVie, Inc.
$867.92 from UCB, Inc.
$553.61 from Celgene Corporation
$467.34 from Horizon Pharma plc
$433.18 from Mallinckrodt LLC
$428.00 from Takeda Pharmaceuticals America, Inc.
$424.46 from E.R. Squibb & Sons, L.L.C.
$415.51 from Genentech USA, Inc.
$362.34 from Janssen Biotech, Inc.
$330.91 from GlaxoSmithKline, LLC.
$228.31 from Antares Pharma, Inc.
$216.35 from Novartis Pharmaceuticals Corporation
$156.84 from MEDAC PHARMA, INC.
$136.33 from LILLY USA, LLC
$124.99 from Supernus Pharmaceuticals, Inc.
$70.49 from Janssen Scientific Affairs, LLC
$48.12 from Gilead Sciences Inc
$46.07 from Depomed, Inc.
Payments received by Dr. Asha Muthalaly, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!